Angioplasty compared to thrombolysis as the initial reperfusion therapy in acute myocardial infarction;Terapia de reperfusión en infarto agudo al miocardio. comparación entre trombolisis endovenosa y angioplastía coronaria

Revista Medica de Chile

Volumn 139, Issue 11, 2011, Pages 1396-1402

  Ugalde, Héctor ^a   Ugalde, Diego ^b   Muñoz, Macarena ^b  

^a HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

Author keywords

Myocardial infarction; Thrombolytic therapy

Indexed keywords

FIBRINOLYTIC AGENT; STREPTOKINASE;

ARTICLE; CHILE; COMPARATIVE STUDY; EPIDEMIOLOGY; FEMALE; FIBRINOLYTIC THERAPY; HEART INFARCTION; HEART MUSCLE REPERFUSION; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; MORTALITY; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ANGIOPLASTY, BALLOON, CORONARY; CHILE; EPIDEMIOLOGIC METHODS; FEMALE; FIBRINOLYTIC AGENTS; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; STREPTOKINASE; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 84856861600     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: 10.4067/S0034-98872011001100002     Document Type: Article

References (36)

1. Solimano G, Mazzei M. ¿De qué mueren los chilenos hoy?: perspectivas para el largo plazo. Rev Med Chile 2007; 135: 932-938.
2. Departamento de Estadísticas e Información en Salud. Ministerio de Salud de Chile 2007; URL: http//deis.minsal.cl/index.asp.
3. Nazzal C, Campos P, Corvalán R, Lanas F, Bartolucci J, Sanhueza P, et al, en representación del Grupo GEMI, Departamento de Estudios Multicéntricos, Sociedad Chilena de Cardiología y Cirugía Cardiovascular. Impacto del plan AUGE en el tratamiento de pacientes con infarto agudo al miocardio con supradesnivel ST, en hospitales chilenos. Rev Med Chile 2008; 136: 1231-9.
4. http://www.minsal.cl/ici/guiasclinicas/infartoagudo.pdf
5. Keeley E, Boura J, Grines C. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomized trials. Lancet 2003; 361: 13-20.
6. Guías de Práctica Clínica de la Sociedad Europea de Cardiología (ESC). Manejo del infarto agudo de miocardio en pacientes con elevación persistente del segment ST Grupo de Trabajo de la Sociedad Europea de Cardiología (ESC) sobre el manejo del infarto agudo de miocardio con elevación del segmento ST (IAMCEST). Rev Esp Cardiol 2009; 62 (3): e1-e47.
7. 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulación 2009; 120: 2271-306.
8. Guarda E, Prieto J, Sanhueza P, Dauvergne C, Asenjo R, Corvalán R. Guías 2009 de la Sociedad Chilena de Cardiología para el tratamiento del Infarto Agudo del Miocardio con supradesnivel del ST. Rev Chil Cardiol 2009; 28: 223-54.
9. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation 2004; 110: e82.
10. Davies M, Woolf N, Robertson W. Pathology of acute myocardial infarction with particular reference to occlusive coronary thrombi. Br Heart J 1976; 38: 659-64.
11. Dewood M, Spores J, Notske R, Mouser L, Burroughs R, Golden M, et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial Infarction. N Engl J Med 1980; 303: 897-902.
12. Rentrop P, Blanke H, Karsh K, Kaiser H, Kostering H, Leitz K. Selective intracoronary thrombolysis in acute myocardial infarction and unstable angina pectoris. Circulation 1981; 63: 307-17.
13. Ganz W, Ninomiya K, Hashida J, Fishbein M, Buchbinder N, Marcus H, et al. Intracoronary thrombolysis in acute myocardial infarction: Experimental background and clinical experience. Am Heart J 1981; 102: 1145-9.
14. GISSI (Gruppo Italiano Per lo Studio Della Streptokinasi Nell Infarto Miocardico) Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986; 1: 397-402
15. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomized trial of intravenous streptokinase, oral aspirin, both or neither among 17187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988; 2: 349-360.
16. Hartzler G, Rumerford B, Mcconahay D, Johnson W, Mccallister B, Gura G, et al. Percutaneous transluminal coronary angioplasty with and without thrombolytic therapy for treatment of acute myocardial infarction. Am Heart J 1983; 106: 965-73
17. Zijlstra F, De Boer M, Hoornje J, Reiffers S, Reiber J, Suryapranata H. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med 1993; 328: 680-4.
18. Akhras F, Abu Ousa A, Swann G, Duncan H, Chamsi-Pasha H, Jabbab H. Primary coronary angioplasty or intravenous thrombolysis for patients with acute myocardial infarction? Acute and late follow-up results in a new cardiac unit. J Am Coll Cardiol 1997; 29 (suppl): A235-6.
19. García E, Elizaga J, Soriano J. Primary angioplasty versus thrombolysis with tPA in anterior myocardial infarction: results from single trial. J Am Coll Cardiol 1997; 29 (suppl): A389.
20. Ribeiro E, Silva L, Carneiro R, D'oliveira L, Gasquez A, Amino J, et al. Randomized trial of direct coronary angioplasty versus intravenous streptokinase in acute myocardial infarction. J Am Coll Cardiol 1993; 22: 376-80.
21. Le May M, Labinaz M, Davies R, Marquis J, Laramee L, O'Brien E, et al. Stenting versus thrombolysis in acute myocardial infarction trial (STAT). J Am Coll Cardiol 2001; 37: 985-91.
22. Gibbons R, Holmes D, Reeder G, Guy S, Bailey K, Hopfenspirger M, et al. Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. N Engl J Med 1993; 328: 685-91.
23. Weaver W, Simes R, Betriu A, Grines C, Zijlstra F, García E, et al. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. JAMA 1997; 278: 2093-8.
24. 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol 1999; 34 (3): 890-911.
25. Chamorro H, Ducci H, Mathei R, Alcaino M, Florenzano F, Ramírez A, et al. Angioplastía coronaria primaria como tratamiento de elección en las primeras 6 horas del infarto de miocardio. Rev Med Chile 1995; 123: 727-34.
26. Ugalde H, Ramírez A, Benavente D, Antúnez M, García S, Dussaillant G, et al. Angioplastía en Infarto Agudo al Miocardio. Resultado inicial y seguimiento alejado. Rev Med Chile 1999; 127: 565-75.
27. Prieto J, Sanhueza C, Martínez N, Nazzal C, Corvalán R, Castro P, et al, del Grupo de Estudio Multicéntrico del Infarto (GEMI). Mortalidad intrahospitalaria en hombres y mujeres según terapias de reperfusión en infarto agudo del miocardio con supradesnivel del ST del Grupo de Estudio Multicéntrico del Infarto (GEMI). Rev Med Chile 2008; 136: 143-50.
28. Greig D, Corbalán R, Castro P, Campos P, Lamich R, Yovaniniz P, et al. Impacto de la trombolisis y de la angioplastia primaria en pacientes con infarto agudo del miocardio tratados en centros hospitalarios terciarios. Rev Med Chile 2008; 136: 1098-106.
29. Martínez A, Nazzal C, Fajuri A, Barra L, Mayerson A, Cavada G, et al. Mortalidad por infarto al miocardio en Chile: comparación de los registros de angioplastía primaria versus trombolisis. Rev Chil Cardiol 2010; 29: 29-36.
30. Chen K, Rha S, Li Y, Poddar K, Jin Z, Minami Y, et al. Triple versus Dual Antiplatelet Therapy in Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. Circulation 2009; 119: 3207-14.
31. Grines C, Cox D, Stone G, García E, Mattos L, Giambartolomei A, et al. Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med 1999; 341: 1949-56.
32. Maillard L, Hamon M, Khalife K, Steg P, Beygui F, Guermonprez J, et al. A comparison of systematic stenting and conventional balloon angioplasty during primary percutaneous transluminal coronary angioplasty for acute myocardial acute myocardial infarction. STENTIM-2 Investigators. J Am Coll Cardiol 2000; 35: 1729-36.
33. Zhu M, Feit A, Chadow H, Alam M, Kwan T, Clarck L. Primary stent implantation compared with primary balloon angioplasty for acute myocardial infarction: a meta analysis of randomised clinical trials. Am J Cardiol 2001; 88: 297-301.
34. Mauri L, Silbaugh T, Garg P, Wolf R, Zelevinsky K, Lovett A, et al. Drug-Eluting or Bare-Metal Stents for Acute Myocardial Infarction. N Engl J Med 2008; 359: 1330-42.
35. Stone G, Lansky A, Pocock S, Gersh B, Dangas G, Wong CH, et al, for the HORIZONS-AMI Trial Investigators*. Paclitaxel-Eluting Stents versus Bare-Metal Stents in Acute Myocardial Infarction.N Engl J Med 2009; 360: 1946-59.
36. Brar SS, León M, Stone G, Mehran R, Moses J, Brar SK, et al. Use of Drug-Eluting Stents in Acute Myocardial Infarction A Systematic Review and Meta-Analysis. J Am Coll Cardiol 2009; 53: 1677-89.